DUO (DUO) Stock Price & Analysis
DUO (DUO) fell 7.84% to USD 0.57 as of July 25, 2026 at 06:51 UTC, according to Nexqual real-time market data.
DUO last closed at USD 0.62; the session ranged USD 0.55–0.61 on volume of 73,902 shares. Market capitalization is $21.90M, with a 52-week range of USD 0.54–5.34 (NCM). Source: Nexqual, July 25, 2026 at 06:51 UTC.
Key Statistics (as of July 25, 2026 at 06:51 UTC)
| Price | USD 0.57 |
|---|---|
| Change | ▼ 7.84% (down) |
| Previous Close | USD 0.62 |
| Open | USD 0.59 |
| Day Range | USD 0.55 – 0.61 |
| 52-Week Range | USD 0.54 – 5.34 |
| Volume | 73,902 shares |
| Market Cap | $21.90M |
| Exchange | NCM |
Technical Analysis (DUO)
Nexqual's technical model rates DUO "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 06:51 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.54 (neutral) |
| vs SMA50 | Below (USD 0.87) |
| MACD | -0.08 (negative) |
Analyst Ratings (DUO)
Wall Street analysts rate DUO "None", per Nexqual as of July 25, 2026 at 06:51 UTC.
| Consensus Rating | None |
|---|
Earnings (DUO)
Source: Nexqual, July 25, 2026 at 06:51 UTC.
Financials & Fundamentals (DUO)
| Total Revenue | $354.82M |
|---|---|
| Revenue Growth (YoY) | -24.00% |
| Gross Margin | +17.92% |
| Operating Margin | -40.64% |
| Profit Margin | -23.87% |
| ROE | -17.88% |
| Debt / Equity | 0.14 |
| Current Ratio | 1.86 |
| Total Cash | $144.20M |
| Total Debt | $806,000 |
| Free Cash Flow | $-89.63M |
Source: Nexqual, July 25, 2026 at 06:51 UTC.
Financial Health Score (DUO)
Nexqual rates DUO's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 06:51 UTC.
| Growth | Critical — Revenue -62% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 18%, operating -41% |
| Balance Sheet | Strong — $144M cash, no debt |
| Cash Flow | Weak — FCF negative: -$90M, burning cash |
| Efficiency | Critical — ROE -18%, ROA -11.0% |
Ownership (DUO)
| Insider Ownership | +0.31% |
|---|---|
| Institutional Ownership | +0.28% |
| Shares Outstanding | 38.53M |
| Float | 38.53M |
| Short % of Float | +0.28% |
Source: Nexqual, July 25, 2026 at 06:51 UTC.
Leadership (DUO)
DUO is led by Xi Zeng (age 43), Co-Founder, CEO & Chairman, per Nexqual as of July 25, 2026 at 06:51 UTC.
| Co-Founder, CEO & Chairman | Xi Zeng (age 43) |
|---|---|
| COO & Director | Jiaorong Pan (age 45) |
| Director of Capital Markets Department | Linda Li |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KAVL | Kaival Brands Innovations Group | USD 0.02 | ▲ 4.76% |
| MTC | MMTec, Inc. | USD 3.04 | ▲ 2.01% |
| SXTC | China SXT Pharmaceuticals, Inc. | USD 0.06 | ▼ 96.84% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
| KXIN | Kaixin Holdings | USD 5.41 | ▼ 1.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:51 UTC. This page is informational and not investment advice.